Agarwal, T. et al. 2019. MUTANT P21 PEPTIDES COULD ACT AS AN IMPROVED CYCLIN A INHIBITORS FOR CANCER THERAPY: AN IN SILICO VALIDATION. International Journal of Pharmacy and Pharmaceutical Sciences. 11, 2 (Feb. 2019), 59–64. DOI:https://doi.org/10.22159/ijpps.2019v11i2.30577.